Health Products

RAN-GABAPENTIN (2015-04-10)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
2582026
Recalling Firm
Ranbaxy Pharmaceuticals Canada Inc.
200-2680 Matheson Blvd. East
Mississauga
L4W 0A5
Ontario
CANADA
Marketing Authorization Holder
Ranbaxy Pharmaceuticals Canada Inc.
200-2680 Matheson Blvd. East
Mississauga
L4W 0A5
Ontario
CANADA
RAN-GabapentinCapsuleDIN 02319055Gabapentin 100 mg

Introduction

Recalled Products

RAN-Gabapentin

Reason

Possibility of contamination with trace amounts of the active ingredient Etodolac.

Depth of distribution

Retailers

Related alerts

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime